External News
LRA's 2020 LMTA Grantees Focus on Finding Targets for New Lupus Drug Development
Read more ➡
External News
Mild COVID-19 disease may trigger long-term immunity
Read more ➡
External News
Benaroya Research Institute president pulls back the curtain on Covid-19 study
Read more ➡Press Release
Thomas N. Wight, PhD, to Retire from Benaroya Research Institute at Virginia Mason
Read More
External News
Newly Discovered Cellular Pathway Blocks Ebola, COVID-19 Viruses
Read more ➡
External News
Science in Seattle: Targeting the Genetic Roots of Autoimmunity
Press Release
Early introduction of gluten may prevent celiac disease in children
Read More
External News
Thu “Kim” Le interns with Benaroya Research Institute, doing cancer research from home
Read more ➡
External News
‘Lost time and momentum’
Press Release
Benaroya Research Institute at Virginia Mason Collaborates to Discover Genes that Block Viral Entry of Ebola and SARS Coronaviruses
Read More
News
Geekwire: Researchers discover new avenue for fighting COVID-19, Ebola and other viral diseases
Read More
Press Release
GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases
Read More
External News
New biotech startup GentiBio lands $20M, inks licensing deals with Seattle Children’s and BRI
Read more ➡
News
GentiBio Joins Cell Therapy Chase With $20M and New Treg Technology
Read More
Press Release
